Patents by Inventor Pallavi Rao

Pallavi Rao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARATION OF ERIBULIN AND INTERMEDIATES THEREOF
    Publication number: 20190276470
    Abstract: The present application relate to process for preparation of tetrahydrofuran compound of formula II, 4-Methylene tetrahydrofuran compound of formula V and tetrahydropyran compound of formula IX which are useful as intermediates for the preparation of halichondrin B analogues such as Eribulin or its pharmaceutically acceptable salts.
    Type: Application
    Filed: November 23, 2017
    Publication date: September 12, 2019
    Inventors: Michael Charles LLOYD, Pallavi RAO, Vishnu Vardhana Vema Reddy EDA, Srinivas ORUGANTI, Kumar SARVESH, Debjit BASU, Raja gopal PENUMANDLA, Prapulla Kumar PALVAI, Amit Kumar MANDAL, Vilas Hareshwar DAHANUKAR, Graham Andrew MEEK, Sarah Ann WARREN, Martin Edward FOX, Robert Wen Ming DAVIDSON
  • SOLID FORMS OF VENETOCLAX AND PROCESSES FOR THE PREPARATION OF VENETOCLAX
    Publication number: 20190185471
    Abstract: Aspects of the present application relate to solid forms of Venetoclax and preparative processes thereof. Specific aspects relate to an amorphous form of Venetoclax, its solid dispersion and crystalline forms of Venetoclax or salts thereof. Further aspects of the present application relate to processes for the preparation of Venetoclax.
    Type: Application
    Filed: June 8, 2017
    Publication date: June 20, 2019
    Applicant: Dr. Reddy's Laboratories Limited
    Inventors: Subba Reddy PEDDI REDDY, Mohan Kumar KOTTUR, Ramprasad JURUPULA, Mohammed Azeezulla BAIG, Ramesh CHAKKA, Rajesh THI PPARABOINA, Vishweshwar PEDDY, Pallavi RAO, Srinivas ORUGANTI, Vilas Hareshwar DAHANUKAR
  • CDK Modulators
    Publication number: 20110201599
    Abstract: A compound according to Formula I: or a pharmaceutically-acceptable salt thereof, wherein R1, R3, A, B and D are as defined in the specification; pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: July 2, 2009
    Publication date: August 18, 2011
    Applicant: EXELIXIS, INC.
    Inventors: Suleyman Bahceci, Bryan Chan, Diva Sze-Ming Chan, Jeff Chen, Timothy Patrick Forsyth, Maurizio Franzini, Vasu Jammalamadaka, Joon Won Jeong, Lisa Renee Jones, Ryan Michael Kelley, Moon Hwan Kim, James W. Leahy, Morrison B. Mac, Robin Tammie Noguchi, Pallavi Rao, Brian Hugh Ridgway, Wei Xu, Yong Wang